AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49

Authors: Papadopoulos, I Sivridis, E Giatromanolaki, A Koukourakis, MI
Citation: I. Papadopoulos et al., Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer, CLIN CANC R, 7(6), 2001, pp. 1533-1538

Authors: Koukourakis, MI Giatromanolaki, A Sivridis, E Simopoulos, K Pastorek, J Wykoff, CC Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy, CLIN CANC R, 7(11), 2001, pp. 3399-3403

Authors: Koukourakis, MI
Citation: Mi. Koukourakis, Clarification on the potential of subcutaneous ethyol as a radioprotectiveagent - Reply, J CL ONCOL, 19(5), 2001, pp. 1582-1583

Authors: Koukourakis, MI Giatromanolaki, A Kakolyris, S Sivridis, E Georgoulias, V Funtzilas, G Hickson, ID Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/REF-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome, INT J RAD O, 50(1), 2001, pp. 27-36

Authors: Giatromanolaki, A Stathopoulos, GP Koukourakis, MI Rigatos, S Vrettou, E Kittas, C Fountzilas, G Sivridis, E
Citation: A. Giatromanolaki et al., Angiogenesis and apoptosis-related protein (p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to paclitaxel and carboplatin chemotherapy, AM J CL ONC, 24(3), 2001, pp. 222-226

Authors: Koukourakis, MI Yannakakis, D
Citation: Mi. Koukourakis et D. Yannakakis, High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequel, ANTICANC R, 21(4B), 2001, pp. 2973-2978

Authors: Koukourakis, MI Corti, L Skarlatos, J Giatromanolaki, A Krammer, B Blandamura, S Piazza, M Verwanger, T Schnitzhofer, G Kostandelos, J Beroukas, K
Citation: Mi. Koukourakis et al., Clinical and experimental evidence of bcl-2 involvement in the response tophotodynamic therapy, ANTICANC R, 21(1B), 2001, pp. 663-668

Authors: Giatromanolaki, A Sivridis, E Stathopoulos, GP Fountzilas, G Kalofonos, HP Tsamandas, A Vrettou, E Scopa, C Polychronidis, A Simopoulos, K Koukourakis, MI
Citation: A. Giatromanolaki et al., Bax protein expression in colorectal cancer: Association with p53, bcl-2 and patterns of relapse, ANTICANC R, 21(1A), 2001, pp. 253-259

Authors: Koukouraki, S Koukourakis, MI Vagios, E Velidaki, A Tsiftsis, D Karkavitsas, N
Citation: S. Koukouraki et al., The role of Tc-99m-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions, NUCL MED C, 22(11), 2001, pp. 1243-1248

Authors: Giatromanolaki, A Sivridis, E Atanassou, N Zois, E Thorpe, PE Brekken, RA Gatter, KC Harris, AL Koukourakis, IM Koukourakis, MI
Citation: A. Giatromanolaki et al., The angiogenic pathway 'vascular endothelial growth factor/flk-I (KDR)-receptor' in rheumatoid arthritis and osteoarthritis, J PATHOLOGY, 194(1), 2001, pp. 101-108

Authors: Koukourakis, MI Giatromanolaki, A Skarlatos, J Corti, L Blandamura, S Piazza, M Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy, CANCER RES, 61(5), 2001, pp. 1830-1832

Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E Pastorek, J Wykoff, CC Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenicpathways and independently to poor outcome in non-small cell lung cancer, CANCER RES, 61(21), 2001, pp. 7992-7998

Authors: Giatromanolaki, A Sivridis, E Brekken, R Thorpe, PE Anastasiadis, P Gatter, KC Harris, AL Koukourakis, MI
Citation: A. Giatromanolaki et al., The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma - Prognostic and therapeutic implications, CANCER, 92(10), 2001, pp. 2569-2577

Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E Turley, H Talks, K Pezzella, F Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival, BR J CANC, 85(6), 2001, pp. 881-890

Authors: Kapsoritakis, AN Koukourakis, MI Sfiridaki, A Potamianos, SP Kosmadaki, MG Koutroubakis, IE Kouroumalis, EA
Citation: An. Kapsoritakis et al., Mean platelet volume: A useful marker of inflammatory bowel disease activity, AM J GASTRO, 96(3), 2001, pp. 776-781

Authors: Koukourakis, MI Giatromanolaki, A Guddo, F Kaklamanis, L Vignola, M Kakolyris, S Turley, H Georgoulias, V Bonsignore, G Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer, J IMMUNOTH, 23(1), 2000, pp. 104-114

Authors: Koukourakis, MI Giatromanolaki, A Kakolyris, S Froudarakis, M Georgoulias, V Retalis, G Bahlitzanakis, N
Citation: Mi. Koukourakis et al., Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer, MED ONCOL, 17(2), 2000, pp. 135-143

Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E O'Byrne, K Cox, G Thorpe, PE Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways, CLIN CANC R, 6(5), 2000, pp. 1917-1921

Authors: Koukourakis, MI Giatromanolaki, A Fountzilas, G Sivridis, E Gatter, KC Harris, AL
Citation: Mi. Koukourakis et al., Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy, CLIN CANC R, 6(2), 2000, pp. 381-389

Authors: Giatromanolaki, A Koukourakis, MI Stathopoulos, GP Kapsoritakis, A Paspatis, G Kakolyris, S Sivridis, E Georgoulias, V Harris, AL Gatter, KC
Citation: A. Giatromanolaki et al., Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer, ONCOL RES, 12(1), 2000, pp. 33-41

Authors: Koukourakis, MI Kyrias, G Kakolyris, S Kouroussis, C Frangiadaki, C Giatromanolaki, A Retalis, G Georgoulias, V
Citation: Mi. Koukourakis et al., Subcutaneous administration of amifostine during fractionated radiotherapy: A randomized phase II study, J CL ONCOL, 18(11), 2000, pp. 2226-2233

Authors: Koukourakis, MI Giatromanolaki, A Sivridis, E Fezoulidis, I
Citation: Mi. Koukourakis et al., Cancer vascularization: Implications in radiotherapy?, INT J RAD O, 48(2), 2000, pp. 545-553

Authors: Corti, L Skarlatos, J Boso, C Cardin, F Kosma, L Koukourakis, MI Giatromanolaki, A Norberto, L Shaffer, M Beroukas, K
Citation: L. Corti et al., Outcome of patients receiving photodynamic therapy for early esophageal cancer, INT J RAD O, 47(2), 2000, pp. 419-424

Authors: Koukourakis, MI Koukouraki, S Giatromanolaki, A Kakolyris, S Georgoulias, V Velidaki, A Archimandritis, S Karkavitsas, NN
Citation: Mi. Koukourakis et al., High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas - Rationale for combination with radiotherapy, ACTA ONCOL, 39(2), 2000, pp. 207-211

Authors: Giatromanolaki, A Koukourakis, MI Sivridis, E Thorpe, PE Brekken, RA Konstantinos, S Fountzilas, G Gatter, KC Harris, AL
Citation: A. Giatromanolaki et al., Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas, CLIN EXP M, 18(4), 2000, pp. 313-319
Risultati: 1-25 | 26-49